Privia Health (PRVA)

• Market cap: $2.41B
• 1 day: -0.30%
• 5 days: -4.34%
• 1 month: -3.46%
• 3 months: 7.04%
• 6 months: 19.61%
• Year to date: -15.35%
• 1 year: -12.59%
• 5 years: -42.24%
• 10 years: -42.24%
• Sector: Healthcare
• Industry: Health Services

About: Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Employees: 1,102

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2,256% more call options, than puts

Call options by funds: $4.97M | Put options by funds: $211K

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

5% more capital invested

Capital invested by funds: $2.07B [Q2] → $2.18B (+$112M) [Q3]

3% more funds holding

Funds holding: 226 [Q2] → 232 (+6) [Q3]

0.47% more ownership

Funds ownership: 99.6% [Q2] → 100.07% (+0.47%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

13% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 89

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $21 5% upside
• Avg. target: $25 24% upside
• High target: $28 40% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Macquarie Tao Qiu 33% 1-year accuracy 5 / 15 met price target	25% upside $25	Outperform Initiated	16 Dec 2024
JP Morgan Lisa Gill 35% 1-year accuracy 7 / 20 met price target	40% upside $28	Overweight Maintained	29 Nov 2024
Barclays Andrew Mok 29% 1-year accuracy 18 / 62 met price target	5% upside $21	Equal-Weight Maintained	8 Nov 2024
Truist Securities Jailendra Singh 14% 1-year accuracy 5 / 35 met price target	35% upside $27	Buy Maintained	8 Nov 2024
Keybanc Matthew Gillmor 27% 1-year accuracy 3 / 11 met price target	15% upside $23	Overweight Initiated	11 Oct 2024